載入...
Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.
One of the current goals in vaccine development is the noninvasive administration of protective antigens via mucosal surfaces. In this context, the gut-associated lymphoid tissues have already been extensively explored. Vaccination via the nasal route has only recently been the focus of intensive in...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
1997
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC176094/ https://ncbi.nlm.nih.gov/pubmed/9009311 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|